Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenxi Tang

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Molecular Reproduction and Development|June 23, 2025
The Bioactive Ingredient Quercetin in Guilu-Erxian-Glue Ameliorates Oligoasthenospermia in Mice via PKA/CREB Pathway-Dependent Sirt1 Activation and p53 DeacetylationYingqiu Li, Xianyu Tian, Minglian Wang, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 25, 2023
Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in MiceChenxi Tang, Li Cen, Hang Zeng, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling PathwayFenglin Luo, Yimeng Tang, Lin Zheng, et al.
Cell Death & Disease|January 16, 2026
NRF1 is upregulated by docosahexaenoic acid to ameliorate MASH through the inhibition of ER stressMengchi Lin, Hongtao Zhang, Shuai Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2022
The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathwayPeihao Liu, Yuwei Zhang, Chenxi Tang, et al.
Frontiers in Oncology|February 13, 2023
Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancerXingsheng Hu, Chunhong Hu, Xianling Liu, et al.
The Journal of Biological Chemistry|March 13, 2021
Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosisMengli Yu, Hao Wu, Jinhai Wang, et al.
Redox Biology|September 20, 2022
MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKTJie Zhang, Li Cen, Xiaofen Zhang, et al.
Experimental & Molecular Medicine|December 22, 2025
Bone marrow-derived CD169<sup>+</sup> macrophages promote autoimmune hepatitis by recruiting CCR2<sup>+</sup> monocytes via secreting CCL12Bingru Lin, Huayang Zhang, Pengwei Zhu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2021
GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltrationYuwei Zhang, Xuefeng Zhou, Peihao Liu, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Reproduction and Development|June 23, 2025
The Bioactive Ingredient Quercetin in Guilu-Erxian-Glue Ameliorates Oligoasthenospermia in Mice via PKA/CREB Pathway-Dependent Sirt1 Activation and p53 DeacetylationYingqiu Li, Xianyu Tian, Minglian Wang, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 25, 2023
Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in MiceChenxi Tang, Li Cen, Hang Zeng, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling PathwayFenglin Luo, Yimeng Tang, Lin Zheng, et al.
Cell Death & Disease|January 16, 2026
NRF1 is upregulated by docosahexaenoic acid to ameliorate MASH through the inhibition of ER stressMengchi Lin, Hongtao Zhang, Shuai Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2022
The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathwayPeihao Liu, Yuwei Zhang, Chenxi Tang, et al.
Frontiers in Oncology|February 13, 2023
Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancerXingsheng Hu, Chunhong Hu, Xianling Liu, et al.
The Journal of Biological Chemistry|March 13, 2021
Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosisMengli Yu, Hao Wu, Jinhai Wang, et al.
Redox Biology|September 20, 2022
MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKTJie Zhang, Li Cen, Xiaofen Zhang, et al.
Experimental & Molecular Medicine|December 22, 2025
Bone marrow-derived CD169<sup>+</sup> macrophages promote autoimmune hepatitis by recruiting CCR2<sup>+</sup> monocytes via secreting CCL12Bingru Lin, Huayang Zhang, Pengwei Zhu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2021
GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltrationYuwei Zhang, Xuefeng Zhou, Peihao Liu, et al.
Pageof 4